Maynard Um
-
-
-
-
-
-
-
Where can biotech stocks go from here? RBC answers
-
-
-
-
-
-
-
Guggenheim on Sionna Therapeutics (SION): 'we continue to believe SION has the potential to revolutionize the cystic fibrosis treatment paradigm with its first-in-class NBD1 stabilizers'
-
-
-
-
-
-
-
TD Cowen Starts Sionna Therapeutics (SION) at Buy
-
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

